The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells
- PMID: 8258197
- DOI: 10.1007/BF00685893
The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells
Abstract
O6-Alkylguanine-DNA alkyltransferase (AGT) activity is associated with resistance of brain tumor cell lines to the cytotoxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). SF-763 cells exhibit high AGT activity and are resistant to BCNU. In this study, we compared the effects of the AGT inhibitor O6-benzylguanine (BG) on the cytotoxicity of BCNU in oxic and hypoxic SF-763 cells; we also measured AGT activity, ornithine decarboxylase (ODC) activity, and polyamine levels to determine if there was any correlation with cell survival as determined by colony-forming efficiency assay. Exponentially growing monolayer cells were pretreated with 10 microM BG for 2 h under oxic or hypoxic (95% nitrogen/5% CO2) conditions and then exposed to graded concentrations of BCNU for 1 h. BG significantly lowered AGT activity but had no cytotoxic effect in oxic or hypoxic cells; hypoxia alone was not cytotoxic. The cytotoxicity of BCNU was 4 times higher in BG-treated hypoxic cells than in oxic cells treated with BCNU alone; the BCNU doses required for a 1-log cell kill were 75 and 300 microM, respectively. ODC activity was lowered by hypoxia alone but was not significantly affected by BG in either hypoxic or oxic cells. Polyamine levels were not significantly affected by hypoxia or BG. These results indicate that pretreatment with BG dramatically lowers AGT activity and increases the cytotoxicity of BCNU in both oxic and hypoxic SF-763 cells. The mechanism of this enhanced cytotoxicity is apparently unrelated to ODC activity or polyamine levels.
Similar articles
-
Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine.Biochem Pharmacol. 1999 Jul 15;58(2):237-44. doi: 10.1016/s0006-2952(99)00095-7. Biochem Pharmacol. 1999. PMID: 10423163
-
Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.Cancer Res. 1994 Aug 15;54(16):4371-5. Cancer Res. 1994. PMID: 8044784
-
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.Br J Cancer. 1996 Oct;74(7):1030-6. doi: 10.1038/bjc.1996.485. Br J Cancer. 1996. PMID: 8855970 Free PMC article.
-
Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea.Cancer Res. 1996 Apr 1;56(7):1578-83. Cancer Res. 1996. PMID: 8603405
-
New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.Forum (Genova). 2000 Jul-Sep;10(3):274-85. Forum (Genova). 2000. PMID: 11007934 Review.
Cited by
-
Inhibition of apoptosis by the retinoblastoma gene product.EMBO J. 1995 Feb 1;14(3):461-72. doi: 10.1002/j.1460-2075.1995.tb07022.x. EMBO J. 1995. PMID: 7859736 Free PMC article.
-
PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.J Neurooncol. 2005 Feb;71(3):215-22. doi: 10.1007/s11060-004-1718-y. J Neurooncol. 2005. PMID: 15735908
-
Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.Br J Cancer. 1996 Feb;73(4):482-90. doi: 10.1038/bjc.1996.85. Br J Cancer. 1996. PMID: 8595163 Free PMC article.
-
O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU.Br J Cancer. 1996 May;73(9):1049-52. doi: 10.1038/bjc.1996.203. Br J Cancer. 1996. PMID: 8624262 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous